We are excited to announce the 12th Anti-Infectives Partnering & Deal-Making Conference, which will take place July 9-10, 2015 in Boston, MA.
Over the years, the anti-infectives field has faced the same challenges in areas such as pricing and reimbursement and overcoming resistance in diseases. However, drug approvals over the past year and President Obama's recent proposal to spend $1.2 billion to address antimicrobial resistance are indications that the field is still changing and evolving.
We invite you to join us as we discuss and seek to answer questions such as, how can we better price antibiotics so that their value to society is better reflected and companies get a better ROI? What has caused the re-emergence of large pharmaceutical companies back into this space and how will that affect the other players? How have FDA guidelines changed and how will that change development? Leaders in the field will provide updates, and dedicated networking sessions will allow colleagues to form connections in an accessible and intimate environment.